Twist Bioscience Quarterly Balance Sheets Chart
Quarterly
|
Annual
Twist Bioscience Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||
| cash and cash equivalents | 201,373,000 | 210,437,000 | 221,403,000 | 226,316,000 | 239,142,000 | 243,348,000 | 266,269,000 | 286,470,000 | 307,459,000 | 315,196,000 | 316,681,000 | 378,687,000 | 376,249,000 | 407,627,000 | 191,624,000 | 465,829,000 | 475,279,000 | 399,329,000 | 348,789,000 | 93,667,000 | 207,853,000 | 184,395,000 | 26,032,000 | 46,735,000 | 68,212,000 | 28,693,000 | 80,757,000 |
| short-term investments | 49,425,000 | 46,710,000 | 49,424,000 | 50,083,000 | 50,276,000 | 49,994,000 | 44,875,000 | 49,943,000 | 49,686,000 | 72,462,000 | 122,029,000 | 126,281,000 | 151,342,000 | 166,231,000 | 110,235,000 | 12,034,000 | 44,129,000 | 156,329,000 | 238,496,000 | 196,335,000 | 103,906,000 | 45,669,000 | 77,075,000 | 91,372,000 | 93,575,000 | 75,631,000 | |
| accounts receivable, net [1] | 49,854,000 | ||||||||||||||||||||||||||
| inventories | 25,938,000 | 20,860,000 | 23,518,000 | 24,078,000 | 28,484,000 | 30,376,000 | 30,863,000 | 32,063,000 | 36,354,000 | 39,923,000 | 44,597,000 | 39,307,000 | 43,022,000 | 44,591,000 | 40,239,000 | 31,800,000 | 21,224,000 | 15,838,000 | 13,409,000 | 12,289,000 | 13,161,000 | 10,764,000 | 7,416,000 | 7,330,000 | 5,496,000 | 4,449,000 | |
| prepaid expenses and other current assets [2] | 13,186,000 | ||||||||||||||||||||||||||
| total current assets | 339,776,000 | 338,442,000 | 345,309,000 | 346,776,000 | 361,831,000 | 371,869,000 | 390,231,000 | 424,256,000 | 445,537,000 | 489,271,000 | 541,859,000 | 596,483,000 | 624,117,000 | 664,375,000 | 385,007,000 | 546,495,000 | 576,607,000 | 607,999,000 | 634,428,000 | 334,870,000 | 344,578,000 | 260,205,000 | 129,288,000 | 160,135,000 | 182,622,000 | 120,991,000 | 95,671,000 |
| property and equipment | 95,351,000 | 97,143,000 | 100,669,000 | 102,520,000 | 106,339,000 | 121,339,000 | 126,225,000 | 131,830,000 | 140,778,000 | 146,539,000 | 144,850,000 | 139,441,000 | 127,011,000 | 91,814,000 | 65,135,000 | 44,122,000 | 37,864,000 | 31,975,000 | 27,153,000 | 25,466,000 | 23,870,000 | 23,266,000 | 21,339,000 | 20,835,000 | 19,817,000 | 14,940,000 | 12,331,000 |
| operating lease right-of-use assets | 51,845,000 | 54,065,000 | 56,475,000 | 58,829,000 | 61,277,000 | 63,666,000 | 69,093,000 | 71,531,000 | 72,028,000 | 70,669,000 | 73,757,000 | 74,948,000 | 76,165,000 | 78,215,000 | 72,020,000 | 61,580,000 | 62,803,000 | 30,997,000 | 32,330,000 | 33,699,000 | 35,064,000 | 35,853,000 | 37,238,000 | ||||
| investment in equity securities | 54,337,000 | ||||||||||||||||||||||||||
| goodwill | 82,195,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,811,000 | 85,678,000 | 84,244,000 | 22,434,000 | 22,676,000 | 1,138,000 | 1,138,000 | 1,138,000 | 1,138,000 | 1,138,000 | 1,138,000 | 1,138,000 | 1,138,000 | 1,138,000 | 1,138,000 |
| intangible assets | 13,688,000 | 13,951,000 | 14,215,000 | 14,478,000 | 14,741,000 | 51,898,000 | 53,190,000 | 54,483,000 | 55,775,000 | 57,068,000 | 58,361,000 | 59,738,000 | 61,115,000 | 62,493,000 | 63,921,000 | 18,262,000 | 18,562,000 | 203,000 | 256,000 | 307,000 | 356,000 | 407,000 | 458,000 | 508,000 | 559,000 | 610,000 | 712,000 |
| restricted cash, non-current | 2,532,000 | 2,510,000 | 2,656,000 | 2,816,000 | 2,895,000 | 2,868,000 | 2,847,000 | 2,811,000 | 4,379,000 | 2,365,000 | 2,410,000 | 1,572,000 | 1,572,000 | 1,572,000 | 1,572,000 | 1,530,000 | 1,530,000 | 1,530,000 | 1,530,000 | 579,000 | 579,000 | 579,000 | 579,000 | 579,000 | 579,000 | 579,000 | 579,000 |
| other non-current assets [3] | 3,881,000 | ||||||||||||||||||||||||||
| total assets | 643,605,000 | 595,615,000 | 608,580,000 | 614,323,000 | 638,118,000 | 702,846,000 | 732,815,000 | 776,403,000 | 810,332,000 | 853,924,000 | 909,970,000 | 961,378,000 | 1,021,636,000 | 786,167,000 | 702,097,000 | 725,298,000 | 677,289,000 | 699,570,000 | 398,882,000 | 408,240,000 | 323,872,000 | 192,277,000 | 186,994,000 | 206,805,000 | 140,170,000 | 115,791,000 | |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||
| accounts payable | 11,985,000 | 8,063,000 | 7,503,000 | 1,630,000 | 6,626,000 | 7,703,000 | 9,256,000 | 14,052,000 | 12,184,000 | 13,236,000 | 20,113,000 | 20,092,000 | 21,014,000 | 16,815,000 | 23,073,000 | 14,900,000 | 11,268,000 | 8,528,000 | 8,932,000 | 4,830,000 | 5,973,000 | 6,932,000 | 9,106,000 | 9,760,000 | 7,835,000 | 4,505,000 | 7,531,000 |
| accrued expenses | 19,535,000 | 19,570,000 | 20,129,000 | 15,104,000 | 14,838,000 | 14,513,000 | 13,959,000 | 10,754,000 | 10,311,000 | 11,156,000 | 10,398,000 | 10,169,000 | 9,499,000 | 15,942,000 | 11,686,000 | 6,437,000 | 4,867,000 | 3,272,000 | 3,510,000 | 3,901,000 | 2,731,000 | 3,491,000 | 4,687,000 | 5,965,000 | 3,713,000 | 2,412,000 | 2,166,000 |
| accrued compensation | 28,972,000 | 24,920,000 | 21,742,000 | 33,650,000 | 31,659,000 | 25,214,000 | 20,787,000 | 25,818,000 | 27,284,000 | 24,280,000 | 23,277,000 | 27,023,000 | 27,698,000 | 21,686,000 | 18,735,000 | 22,327,000 | 19,523,000 | 14,897,000 | 11,577,000 | 14,945,000 | 11,298,000 | 8,625,000 | 8,848,000 | 10,479,000 | |||
| current portion of operating lease liability | 15,501,000 | 15,218,000 | 15,030,000 | 14,805,000 | 14,555,000 | 14,621,000 | 14,808,000 | 14,896,000 | 13,132,000 | 13,396,000 | 14,227,000 | 13,642,000 | 14,352,000 | 14,166,000 | 12,684,000 | 8,213,000 | 6,444,000 | 6,409,000 | |||||||||
| other current liabilities | 11,077,000 | 7,205,000 | 5,242,000 | 5,817,000 | 6,079,000 | 5,439,000 | 6,418,000 | 7,803,000 | 9,911,000 | 10,040,000 | 15,822,000 | 19,737,000 | 20,123,000 | 16,023,000 | 13,856,000 | 9,623,000 | 9,265,000 | 4,063,000 | 3,306,000 | 2,611,000 | 1,373,000 | 52,000 | 999,000 | 817,000 | 680,000 | 894,000 | 939,000 |
| total current liabilities | 87,070,000 | 74,976,000 | 69,646,000 | 71,006,000 | 73,757,000 | 67,490,000 | 65,228,000 | 73,323,000 | 72,822,000 | 72,108,000 | 83,837,000 | 90,663,000 | 92,686,000 | 84,632,000 | 80,034,000 | 63,052,000 | 54,833,000 | 40,442,000 | 37,102,000 | 36,029,000 | 31,377,000 | 30,210,000 | 57,844,000 | 30,354,000 | 25,447,000 | 18,580,000 | 18,537,000 |
| operating lease liability, net of current portion | 62,649,000 | 65,080,000 | 67,586,000 | 70,221,000 | 72,625,000 | 74,804,000 | 77,070,000 | 79,173,000 | 79,900,000 | 77,824,000 | 79,748,000 | 81,270,000 | 64,244,000 | 65,496,000 | 60,285,000 | 53,156,000 | 23,681,000 | 24,837,000 | |||||||||
| liability related to the sale of future revenue | 15,000,000 | 15,000,000 | 15,000,000 | ||||||||||||||||||||||||
| other non-current liabilities[4] | 688,000 | ||||||||||||||||||||||||||
| total liabilities | 165,407,000 | 155,507,000 | 152,639,000 | 141,634,000 | 146,979,000 | 142,715,000 | 142,773,000 | 152,971,000 | 152,782,000 | 149,992,000 | 163,645,000 | 171,993,000 | 158,275,000 | 159,989,000 | 121,276,000 | 114,850,000 | 63,108,000 | 61,618,000 | 62,620,000 | 59,294,000 | 59,670,000 | 89,196,000 | 34,912,000 | 30,802,000 | 24,690,000 | 26,730,000 | |
| commitments and contingencies | |||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||
| common stock | |||||||||||||||||||||||||||
| additional paid-in capital | 1,771,502,000 | 1,753,600,000 | 1,730,092,000 | 1,715,119,000 | 1,699,127,000 | 1,682,473,000 | 1,666,797,000 | 1,657,222,000 | 1,644,976,000 | 1,633,217,000 | 1,617,174,000 | 1,619,644,000 | 1,599,355,000 | 1,580,620,000 | 1,281,931,000 | 1,190,828,000 | 1,179,331,000 | 1,143,265,000 | 1,129,165,000 | 794,630,000 | 782,949,000 | 669,919,000 | 477,053,000 | 470,425,000 | 463,229,000 | 375,043,000 | 9,346,000 |
| accumulated other comprehensive income/ | -864,000 | -662,000 | -649,000 | -635,000 | |||||||||||||||||||||||
| accumulated deficit | -1,292,440,000 | -1,312,830,000 | -1,273,502,000 | -1,241,908,000 | -1,207,253,000 | -1,121,682,000 | -1,076,190,000 | -1,033,034,000 | -986,791,000 | -929,396,000 | -870,240,000 | -828,416,000 | -777,301,000 | -716,784,000 | -656,116,000 | -610,553,000 | -569,311,000 | -529,274,000 | -491,355,000 | -458,455,000 | -434,137,000 | -405,930,000 | -374,162,000 | -318,524,000 | -287,343,000 | -259,427,000 | -210,855,000 |
| total stockholders’ equity | 478,198,000 | 440,108,000 | 455,941,000 | 472,689,000 | 491,139,000 | 560,131,000 | 590,042,000 | 623,432,000 | 657,550,000 | 703,932,000 | 746,325,000 | 789,385,000 | 820,677,000 | 863,361,000 | 626,178,000 | 580,821,000 | 610,448,000 | 614,181,000 | 637,952,000 | 336,262,000 | 348,946,000 | 264,202,000 | 103,081,000 | 152,082,000 | 176,003,000 | 115,480,000 | -201,422,000 |
| total liabilities and stockholders’ equity | 643,605,000 | 595,615,000 | 608,580,000 | 614,323,000 | 638,118,000 | 702,846,000 | 732,815,000 | 776,403,000 | 810,332,000 | 853,924,000 | 909,970,000 | 961,378,000 | 979,663,000 | 1,021,636,000 | 786,167,000 | 702,097,000 | 725,298,000 | 677,289,000 | 699,570,000 | 398,882,000 | 408,240,000 | 323,872,000 | 192,277,000 | ||||
| accounts receivable | 49,949,000 | 39,315,000 | 34,903,000 | 31,988,000 | 35,993,000 | 35,354,000 | 44,064,000 | 42,580,000 | 48,187,000 | 44,437,000 | 40,294,000 | 41,195,000 | 34,877,000 | 32,872,000 | 28,549,000 | 28,116,000 | 27,290,000 | 25,492,000 | 26,376,000 | 13,347,000 | 14,831,000 | 13,054,000 | 12,104,000 | 11,697,000 | 7,998,000 | 5,419,000 | |
| prepaid expenses and other current assets | 10,486,000 | 11,649,000 | 11,396,000 | 11,941,000 | 12,158,000 | 12,870,000 | 11,716,000 | 9,458,000 | 13,503,000 | 14,115,000 | 11,914,000 | 12,309,000 | 11,049,000 | 10,037,000 | 8,283,000 | 7,859,000 | 9,213,000 | 8,242,000 | 6,203,000 | 6,311,000 | 4,546,000 | 5,711,000 | 2,594,000 | 3,642,000 | 4,220,000 | 3,467,000 | |
| other non-current assets | 3,693,000 | 3,445,000 | 3,093,000 | 5,224,000 | 5,395,000 | 5,418,000 | 5,681,000 | 6,024,000 | 2,201,000 | 2,922,000 | 3,385,000 | 3,872,000 | 6,902,000 | 7,425,000 | 7,674,000 | 5,256,000 | 3,447,000 | 2,735,000 | 2,823,000 | 2,655,000 | 2,424,000 | 2,237,000 | 3,799,000 | 2,090,000 | 1,912,000 | 5,360,000 | |
| other non-current liabilities | 451,000 | 407,000 | 407,000 | 597,000 | 421,000 | 475,000 | 475,000 | 60,000 | 60,000 | 60,000 | 60,000 | 2,056,000 | 8,147,000 | 19,670,000 | 5,068,000 | 6,168,000 | 422,000 | 210,000 | 351,000 | 95,000 | 144,000 | 158,000 | 236,000 | 282,000 | 344,000 | ||
| accumulated other comprehensive loss | -522,000 | -756,000 | |||||||||||||||||||||||||
| accumulated other comprehensive income | -735,000 | -660,000 | -565,000 | 111,000 | -609,000 | -1,377,000 | -475,000 | 363,000 | 546,000 | 428,000 | 190,000 | 142,000 | 87,000 | 134,000 | 213,000 | 190,000 | 181,000 | 117,000 | -136,000 | 87,000 | |||||||
| current portion of long-term debt | 1,552,000 | 2,365,000 | 3,168,000 | 3,333,000 | 3,333,000 | 3,333,000 | 3,333,000 | 3,333,000 | 3,333,000 | 3,333,000 | 3,333,000 | 2,500,000 | |||||||||||||||
| accumulated other comprehensive (loss)/income | -1,843,000 | ||||||||||||||||||||||||||
| total assets [1] | 979,663,000 | ||||||||||||||||||||||||||
| total liabilities [1] | 158,986,000 | ||||||||||||||||||||||||||
| long term investments | 30,587,000 | ||||||||||||||||||||||||||
| long term investment | 106,843,000 | ||||||||||||||||||||||||||
| long-term debt, net of current portion | 625,000 | 1,403,000 | 2,170,000 | 2,925,000 | 3,669,000 | 4,400,000 | 5,119,000 | 5,828,000 | 7,218,000 | ||||||||||||||||||
| current assets | |||||||||||||||||||||||||||
| current liabilities | |||||||||||||||||||||||||||
| current portion of operating lease liabilities | 7,545,000 | 6,514,000 | 6,669,000 | 7,777,000 | 8,371,000 | ||||||||||||||||||||||
| operating lease liabilities, net of current portion | 53,849,000 | 22,244,000 | 25,747,000 | 26,440,000 | 27,539,000 | ||||||||||||||||||||||
| preferred stock, 0.00001 par value—10,000,000 shares authorized; no shares issued or outstanding | |||||||||||||||||||||||||||
| accrued litigation settlement | 22,500,000 | ||||||||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders’ equity | |||||||||||||||||||||||||||
| redeemable convertible preferred stock | 631,000 | ||||||||||||||||||||||||||
| series a redeemable convertible preferred stock, 0.00001 par value—no shares and 2,854,576 shares authorized as of september 30, 2019 and 2018; no shares and 2,817,723 shares issued and outstanding as of september 30, 2019 and 2018. | |||||||||||||||||||||||||||
| series b redeemable convertible preferred stock, 0.00001 par value—no shares and 3,331,878 shares authorized as of september 30, 2019 and 2018; no shares and 3,315,645 shares issued and outstanding as of september 30, 2019 and 2018. | |||||||||||||||||||||||||||
| series c redeemable convertible preferred stock, 0.00001 par value—no shares and 2,510,354 shares authorized as of september 30, 2019 and 2018; no shares and 2,491,483 shares issued and outstanding as of september 30, 2019 and 2018. | |||||||||||||||||||||||||||
| series d redeemable convertible preferred stock, 0.00001 par value—no shares and 10,475,252 shares authorized as of september 30, 2019 and 2018, respectively; no shares and 10,326,454 shares issued and outstanding as of september 30, 2019 and 2018, respectively. | |||||||||||||||||||||||||||
| total redeemable convertible preferred stock | 290,483,000 | ||||||||||||||||||||||||||
| preferred stock, 0.00001 par value—10,000,000 shares and no shares authorized as of september 30, 2019 and 2018, respectively; no shares issued or outstanding as of september 30, 2019 and 2018, respectively. | |||||||||||||||||||||||||||
| total liabilities, redeemable convertible preferred stock and stockholders’ equity | 186,994,000 | 206,805,000 | 140,170,000 | 115,791,000 | |||||||||||||||||||||||
| accrued payroll | 9,886,000 | 7,436,000 | 5,401,000 | ||||||||||||||||||||||||
| series a redeemable convertible preferred stock, 0.00001 par value—2,854,576 shares and no shares authorized as of september 30, 2018 and june 30, 2019, respectively; 2,817,723 shares and no shares issued and outstanding as of september 30, 2018 and june 30, 2019, respectively. | |||||||||||||||||||||||||||
| series b redeemable convertible preferred stock, 0.00001 par value—3,331,878 shares and no shares authorized as of september 30, 2018 and june 30, 2019, respectively; 3,315,645 shares and no shares issued and outstanding as of september 30, 2018 and june 30, 2019, respectively. | |||||||||||||||||||||||||||
| series c redeemable convertible preferred stock, 0.00001 par value—2,510,354 shares and no shares authorized as of september 30, 2018 and june 30, 2019, respectively; 2,491,483 shares and no shares issued and outstanding as of september 30, 2018 and june 30, 2019, respectively. | |||||||||||||||||||||||||||
| series d redeemable convertible preferred stock, 0.00001 par value—10,475,252 shares and no shares authorized as of september 30, 2018 and june 30, 2019, respectively; 10,326,454 shares and no shares issued and outstanding as of september 30, 2018 and june 30, 2019, respectively. | |||||||||||||||||||||||||||
| preferred stock, 0.00001 par value—no shares and 10,000,000 shares authorized as of september 30, 2018 and june 30, 2019, respectively; no shares issued or outstanding as of september 30, 2018 and june 30, 2019, respectively. | |||||||||||||||||||||||||||
| series a redeemable convertible preferred stock, 0.00001 par value—2,854,576 shares and no shares authorized as of september 30, 2018 and march 31, 2019, respectively; 2,817,723 shares and no shares issued and outstanding as of september 30, 2018 and march 31, 2019, respectively. | |||||||||||||||||||||||||||
| series b redeemable convertible preferred stock, 0.00001 par value—3,331,878 shares and no shares authorized as of september 30, 2018 and march 31, 2019, respectively; 3,315,645 shares and no shares issued and outstanding as of september 30, 2018 and march 31, 2019, respectively. | |||||||||||||||||||||||||||
| series c redeemable convertible preferred stock, 0.00001 par value—2,510,354 shares and no shares authorized as of september 30, 2018 and march 31, 2019, respectively; 2,491,483 shares and no shares issued and outstanding as of september 30, 2018 and march 31, 2019, respectively. | |||||||||||||||||||||||||||
| series d redeemable convertible preferred stock, 0.00001 par value—10,475,252 shares and no shares authorized as of september 30, 2018 and march 31, 2019, respectively; 10,326,454 shares and no shares issued and outstanding as of september 30, 2018 and march 31, 2019, respectively. | |||||||||||||||||||||||||||
| preferred stock, 0.00001 par value—no shares and 10,000,000 shares authorized as of september 30, 2018 and march 31, 2019, respectively; no shares issued or outstanding as of september 30, 2018 and march 31, 2019, respectively. | |||||||||||||||||||||||||||
| inventory | 6,028,000 | ||||||||||||||||||||||||||
| series a redeemable convertible preferred stock, 0.00001 par value—2,854,576 shares and no shares authorized as of september 30, 2018 and december 31, 2018, respectively; 2,817,723 shares and no shares issued and outstanding as of september 30, 2018 and december 31, 2018 respectively. | 9,141,000 | ||||||||||||||||||||||||||
| series b redeemable convertible preferred stock, 0.00001 par value—3,331,878 shares and no shares authorized as of september 30, 2018 and december 31, 2018, respectively; 3,315,645 shares and no shares issued and outstanding as of september 30, 2018 and december 31, 2018, respectively. | 25,900,000 | ||||||||||||||||||||||||||
| series c redeemable convertible preferred stock, 0.00001 par value—2,510,354 shares and no shares authorized as of september 30, 2018 and december 31, 2018, respectively; 2,491,483 shares and no shares issued and outstanding as of september 30, 2018 and december 31, 2018, respectively. | 36,726,000 | ||||||||||||||||||||||||||
| series d redeemable convertible preferred stock, 0.00001 par value—10,475,252 shares and no shares authorized as of september 30, 2018 and december 31, 2018, respectively; 10,326,454 shares and no shares issued and outstanding as of september 30, 2018 and december 31, 2018, respectively. | 218,716,000 | ||||||||||||||||||||||||||
| preferred stock, 0.00001 par value—no shares and 10,000,000 shares authorized as of september 30, 2018 and december 31, 2018, respectively; no shares issued or outstanding as of september 30, 2018 and december 31, 2018, respectively. |
We provide you with 20 years of balance sheets for Twist Bioscience stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Twist Bioscience. Explore the full financial landscape of Twist Bioscience stock with our expertly curated balance sheets.
The information provided in this report about Twist Bioscience stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.